Glutathione has attracted significant attention in dermatology -but separating clinical evidence from marketing claims is genuinely difficult
Malondialdehyde: facts and artifacts
Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
Begin by providing the patient information
Importantly, after adding the covariates, i.e., BMI ( p .010), sex ( p .019), years with SAD ( p .012), smoking ( p .004), concurrent SSRIs ( p .017), and prepost change in proportion of lymphocytes to monocytes ( p 0.020), the significant relationships remained between changes in LSAS-SR symptoms and telomerase and GPx activity, respectively